Filtered By:
Education: Study
Procedure: Angioplasty

This page shows you your search results in order of date. This is page number 17.

Order by Relevance | Date

Total 2927 results found since Jan 2013.

Clinical Characteristics and Outcomes of Chinese Patients with Premature Acute Coronary Syndrome
This study aimed to investigate the clinical characteristics and major adverse cardiovascular events (MACEs) of Chinese patients with premature acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). This study was a secondary retrospective analysis involving 2114 ACS patients undergoing PCI at a single center in China. The patients were divided into two groups according to age (premature ACS group: ≤ 55 years in men, ≤ 65 years in women; nonpremature ACS group: > 55 years in men, > 65 years in women). The primary endpoint was all-cause death, and the secondary endpoint was a composite ...
Source: International Heart Journal - March 17, 2023 Category: Cardiology Authors: Jian-Di Liu Ren Gong Jin-Song Xu Shi-Yuan Zhang Yan-Qing Wu Source Type: research

Safety and feasibility of minimally invasive coronary artery bypass surgery early after drug eluting stent implantation due to acute coronary syndrome
CONCLUSIONS: EACAB is a safe and feasible method of LAD revascularization in patients who received DES for ACS within 180 days prior to surgery, despite early dual antiplatelet therapy discontinuation. The adverse event rate is low and acceptable.PMID:36929299 | DOI:10.33963/KP.a2023.0066
Source: Kardiologia Polska - March 17, 2023 Category: Cardiology Authors: Krzysztof Sanetra Piotr P Buszman Piotr P Buszman Justyna Jankowska-Sanetra Justyna Jankowska-Sanetra Marta Konopko Marta Konopko Monika Slabon-Turska Monika Slabon-Turska Krzysztof Bia łek Krzysztof Bia łek Krzysztof Milewski Krzysztof Milewski Witold Source Type: research

Clinical Characteristics and Outcomes of Chinese Patients with Premature Acute Coronary Syndrome
This study aimed to investigate the clinical characteristics and major adverse cardiovascular events (MACEs) of Chinese patients with premature acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). This study was a secondary retrospective analysis involving 2114 ACS patients undergoing PCI at a single center in China. The patients were divided into two groups according to age (premature ACS group: ≤ 55 years in men, ≤ 65 years in women; nonpremature ACS group: > 55 years in men, > 65 years in women). The primary endpoint was all-cause death, and the secondary endpoint was a composite ...
Source: International Heart Journal - March 17, 2023 Category: Cardiology Authors: Jian-Di Liu Ren Gong Jin-Song Xu Shi-Yuan Zhang Yan-Qing Wu Source Type: research

Safety and feasibility of minimally invasive coronary artery bypass surgery early after drug eluting stent implantation due to acute coronary syndrome
CONCLUSIONS: EACAB is a safe and feasible method of LAD revascularization in patients who received DES for ACS within 180 days prior to surgery, despite early dual antiplatelet therapy discontinuation. The adverse event rate is low and acceptable.PMID:36929299 | DOI:10.33963/KP.a2023.0066
Source: Polish Heart Journal - March 17, 2023 Category: Cardiology Authors: Krzysztof Sanetra Piotr P Buszman Piotr P Buszman Justyna Jankowska-Sanetra Justyna Jankowska-Sanetra Marta Konopko Marta Konopko Monika Slabon-Turska Monika Slabon-Turska Krzysztof Bia łek Krzysztof Bia łek Krzysztof Milewski Krzysztof Milewski Witold Source Type: research

Clinical Characteristics and Outcomes of Chinese Patients with Premature Acute Coronary Syndrome
This study aimed to investigate the clinical characteristics and major adverse cardiovascular events (MACEs) of Chinese patients with premature acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). This study was a secondary retrospective analysis involving 2114 ACS patients undergoing PCI at a single center in China. The patients were divided into two groups according to age (premature ACS group: ≤ 55 years in men, ≤ 65 years in women; nonpremature ACS group: > 55 years in men, > 65 years in women). The primary endpoint was all-cause death, and the secondary endpoint was a composite ...
Source: International Heart Journal - March 17, 2023 Category: Cardiology Authors: Jian-Di Liu Ren Gong Jin-Song Xu Shi-Yuan Zhang Yan-Qing Wu Source Type: research

Safety and feasibility of minimally invasive coronary artery bypass surgery early after drug eluting stent implantation due to acute coronary syndrome
CONCLUSIONS: EACAB is a safe and feasible method of LAD revascularization in patients who received DES for ACS within 180 days prior to surgery, despite early dual antiplatelet therapy discontinuation. The adverse event rate is low and acceptable.PMID:36929299 | DOI:10.33963/KP.a2023.0066
Source: Polish Heart Journal - March 17, 2023 Category: Cardiology Authors: Krzysztof Sanetra Piotr P Buszman Piotr P Buszman Justyna Jankowska-Sanetra Justyna Jankowska-Sanetra Marta Konopko Marta Konopko Monika Slabon-Turska Monika Slabon-Turska Krzysztof Bia łek Krzysztof Bia łek Krzysztof Milewski Krzysztof Milewski Witold Source Type: research

Clinical Characteristics and Outcomes of Chinese Patients with Premature Acute Coronary Syndrome
This study aimed to investigate the clinical characteristics and major adverse cardiovascular events (MACEs) of Chinese patients with premature acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). This study was a secondary retrospective analysis involving 2114 ACS patients undergoing PCI at a single center in China. The patients were divided into two groups according to age (premature ACS group: ≤ 55 years in men, ≤ 65 years in women; nonpremature ACS group: > 55 years in men, > 65 years in women). The primary endpoint was all-cause death, and the secondary endpoint was a composite ...
Source: International Heart Journal - March 17, 2023 Category: Cardiology Authors: Jian-Di Liu Ren Gong Jin-Song Xu Shi-Yuan Zhang Yan-Qing Wu Source Type: research

Safety and feasibility of minimally invasive coronary artery bypass surgery early after drug eluting stent implantation due to acute coronary syndrome
CONCLUSIONS: EACAB is a safe and feasible method of LAD revascularization in patients who received DES for ACS within 180 days prior to surgery, despite early dual antiplatelet therapy discontinuation. The adverse event rate is low and acceptable.PMID:36929299 | DOI:10.33963/KP.a2023.0066
Source: Kardiologia Polska - March 17, 2023 Category: Cardiology Authors: Krzysztof Sanetra Piotr P Buszman Piotr P Buszman Justyna Jankowska-Sanetra Justyna Jankowska-Sanetra Marta Konopko Marta Konopko Monika Slabon-Turska Monika Slabon-Turska Krzysztof Bia łek Krzysztof Bia łek Krzysztof Milewski Krzysztof Milewski Witold Source Type: research

Clinical Characteristics and Outcomes of Chinese Patients with Premature Acute Coronary Syndrome
This study aimed to investigate the clinical characteristics and major adverse cardiovascular events (MACEs) of Chinese patients with premature acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). This study was a secondary retrospective analysis involving 2114 ACS patients undergoing PCI at a single center in China. The patients were divided into two groups according to age (premature ACS group: ≤ 55 years in men, ≤ 65 years in women; nonpremature ACS group: > 55 years in men, > 65 years in women). The primary endpoint was all-cause death, and the secondary endpoint was a composite ...
Source: International Heart Journal - March 17, 2023 Category: Cardiology Authors: Jian-Di Liu Ren Gong Jin-Song Xu Shi-Yuan Zhang Yan-Qing Wu Source Type: research

Safety and feasibility of minimally invasive coronary artery bypass surgery early after drug eluting stent implantation due to acute coronary syndrome
CONCLUSIONS: EACAB is a safe and feasible method of LAD revascularization in patients who received DES for ACS within 180 days prior to surgery, despite early dual antiplatelet therapy discontinuation. The adverse event rate is low and acceptable.PMID:36929299 | DOI:10.33963/KP.a2023.0066
Source: Polish Heart Journal - March 17, 2023 Category: Cardiology Authors: Krzysztof Sanetra Piotr P Buszman Piotr P Buszman Justyna Jankowska-Sanetra Justyna Jankowska-Sanetra Marta Konopko Marta Konopko Monika Slabon-Turska Monika Slabon-Turska Krzysztof Bia łek Krzysztof Bia łek Krzysztof Milewski Krzysztof Milewski Witold Source Type: research